RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/Ouxioo6bh0
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @banavarrete: Acaba de salir el primer trabajo sobre Remdesivir en #COVID19 en @NEJM. Se trata de los datos de un programa de uso compas…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @phalsaydalani: Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/m0mP5mY4ov
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @mikecolacci: Looking forward to RCT results for remdesivir. Here is some early, uncontrolled data: https://t.co/AO40QkxFEL
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
If you compare the crit ill pt requiring invasive ventilation, 6/34 (18%) died, compared to 44/67 (66%) died in this paper. https://t.co/Y2RlQuoedo. I hope @GileadSciences is doing interim analysis on the controlled trials right now.
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @Cooganlab: Whilst we await results from RCTs, this is the most promising indications yet that Remesdivir has efficacy for severe COVID1…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Not a a RCT (yet) but #remdesevir shows promise is some of most sever COVID-19 patients. Big studies will tell us more but there is some hope https://t.co/Z7sxuG22Pm
RT @csentropy: Great news on Remdesivir: https://t.co/HwduOTk5Jx Dramatic effect matters
RT @gary_lyman: #CCC19 #oncoalert Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/zp4Bn43me9 Cohort h…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/TMjGFV1HCP
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EdBelongia: Some encouraging news on remdesivir. This @NEJM analysis had no control group and is inconclusive, but outcomes were better…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
#CCC19 #oncoalert Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/zp4Bn43me9 Cohort hospitalized for severe Covid19 treated with remdesivir, clinical improvement in 36/53(68%) @nicolekuderer @COVID19nCCC @pergamIC @uwd
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
NEJMの報告。新型コロナウイルス重症患者53人に対するエボラ用のレムデシビル投与の効果。 36/58人 (68%) 改善 酸素の補給あり。 17/30 (57%)人工呼吸器 25/53 (47%)退院 7/53 (13%)死亡 https://t.co/GE5IrZu4al
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @banavarrete: Acaba de salir el primer trabajo sobre Remdesivir en #COVID19 en @NEJM. Se trata de los datos de un programa de uso compas…
Great news on Remdesivir: https://t.co/HwduOTk5Jx Dramatic effect matters
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @paomorejon: 📌Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 Improvement in oxygen-support status was observed in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @mikecolacci: Looking forward to RCT results for remdesivir. Here is some early, uncontrolled data: https://t.co/AO40QkxFEL
From the @NEJM: There was significant improvement in 53 critically ill COVID-19 patients treated with compassionate-use remdesivir, a positive sign. https://t.co/QXPvZ8x3a3
RT @Dr_Aust_PhD: This looks encouraging for an early trial. Remdesivir is an inhibitor of the viral (RNA-dep) RNA polymerase. If this holds…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe #Covid19 | NEJM https://t.co/LTUaRPhtrk
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
NEW: @NEJM just published data from 53 patients w severe COVID-19 receiving compassionate-use remdesivir. *No* randomized control, so data does *not* confirm whether remdesivir is safe & effective. - 36/53 saw improvement - 25/53 discharged - 7/53 died
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @snamendys: Pts hospitalized for severe #COVID-19 who were treated with compassionate-use remdesivir, clinical improvement was observed…
Can't compare that 18% fatality rate on remdesivir to natural history of severe COVID. Most patients (53%) are still in the hospital. More accurate to compare when that 53% recovers or not — the 18% fatality rate will only go up with time. It's promising
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
This is much better worded than the hydroxy chloroquine data
Good news! Remdesivir shows positibe effect.
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @megtirrell: From NEJM article on compassionate use of Gilead’s remdesivir, a breakdown of each patient’s improvement level https://t.co…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…